miR-483-3p promotes cell proliferation and suppresses apoptosis in rheumatoid arthritis fibroblast-like synoviocytes by targeting IGF-1.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Yuejiao WangNing Zhang

Abstract

Accumulating evidence suggests that miR-483-3p is implicated in maintaining biological properties in human cancers. However, its biological roles in rheumatoid arthritis (RA) remain unknown. miR-483-3p levels in synovial tissue samples and fibroblast-like synoviocytes (FLSs) were determined using quantitative real-time PCR. The CCK-8 assay and EdU staining were performed to assess cell proliferation in RA FLSs after transfection with miR-483-3p mimics or inhibitor. Flow cytometry with Annexin V-FITC staining or PI staining was performed to assess apoptosis or cell cycle progression in RA FLSs, respectively. miR-483-3p was upregulated in RA, which markedly promoted cell proliferation, induced the G0/G1-to-S phase transition, and suppressed apoptosis in RA FLSs, whereas miR-483-3p silencing yielded opposite results. Moreover, insulin growth factor 1 (IGF-1) was detected as a direct miR-483-3p target. IGF-1 silencing partially restored cell proliferation, the G0/G1-to-S phase transition, and apoptosis suppression in RA FLSs via miR-483-3p inhibition. Our results showed that miR-483-3p promotes RA FLSs proliferation by targeting IGF-1, suggesting a potential strategy for diagnostic and treatment strategy for RA.

References

Oct 27, 2001·Science·M Lagos-QuintanaT Tuschl
Nov 14, 2012·Nature Reviews. Rheumatology·Nunzio Bottini, Gary S Firestein
Jul 1, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Cuiping WangJie Chen
Aug 13, 2015·ELife·Vikram AgarwalDavid P Bartel
Jun 28, 2016·Biochemical and Biophysical Research Communications·Yu QiaoHui Huang
Jun 15, 2017·Lancet·Gerd R Burmester, Janet E Pope
May 17, 2018·Nature Communications·Rizi AiGary S Firestein
Jun 17, 2018·EMBO Molecular Medicine·Catrin YoussifAngel R Nebreda
Aug 4, 2018·Journal of Cellular and Molecular Medicine·Zhengke ZhiWeibing Tang
Sep 9, 2018·Annals of the Rheumatic Diseases·Nadia M T RoodenrijsUNKNOWN whole EULAR Task Force on development of EULAR recommendations for the comprehensive management of difficult-to-treat rheuma
Feb 6, 2019·JAMA : the Journal of the American Medical Association·Daniel Aletaha, Josef S Smolen
Sep 11, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·YueJiao WangNing Zhang
Sep 15, 2019·Autoimmunity Reviews·Gerasimos EvangelatosGeorge I Lambrou
Jan 25, 2020·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Wen Shi LeeTatsuya Atsumi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis